Andre F - Search Results

1

Quantification of residual risk of relapse in breast cancer patients optimally treated.

Dieci MV, Arnedos M, Delaloge S, Andre F. Dieci MV, et al. Among authors: andre f. Breast. 2013 Aug;22 Suppl 2:S92-5. doi: 10.1016/j.breast.2013.07.017. Breast. 2013. PMID: 24074801 Free article. Review.

2

Breast cancer with synchronous metastases: trends in survival during a 14-year period.

Andre F, Slimane K, Bachelot T, Dunant A, Namer M, Barrelier A, Kabbaj O, Spano JP, Marsiglia H, Rouzier R, Delaloge S, Spielmann M. Andre F, et al. J Clin Oncol. 2004 Aug 15;22(16):3302-8. doi: 10.1200/JCO.2004.08.095. J Clin Oncol. 2004. PMID: 15310773

3

Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors.

Rouzier R, Mathieu MC, Sideris L, Youmsi E, Rajan R, Garbay JR, André F, Marsiglia H, Spielmann M, Delaloge S. Rouzier R, et al. Among authors: andre f. Cancer. 2004 Sep 1;101(5):918-25. doi: 10.1002/cncr.20491. Cancer. 2004. PMID: 15329898 Free article.

4

Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancer.

Andre F, Khalil A, Slimane K, Massard C, Mathieu MC, Vignot S, Assi H, Delaloge S, Spielmann M. Andre F, et al. J Clin Oncol. 2005 May 1;23(13):2996-3000. doi: 10.1200/JCO.2005.08.046. J Clin Oncol. 2005. PMID: 15860855 Clinical Trial.

5

Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer.

Rouzier R, Pusztai L, Delaloge S, Gonzalez-Angulo AM, Andre F, Hess KR, Buzdar AU, Garbay JR, Spielmann M, Mathieu MC, Symmans WF, Wagner P, Atallah D, Valero V, Berry DA, Hortobagyi GN. Rouzier R, et al. Among authors: andre f. J Clin Oncol. 2005 Nov 20;23(33):8331-9. doi: 10.1200/JCO.2005.01.2898. J Clin Oncol. 2005. PMID: 16293864

6

Heterogeneity of breast cancer among patients and implications for patient selection for adjuvant chemotherapy.

Andre F, Pusztai L. Andre F, et al. Pharm Res. 2006 Sep;23(9):1951-8. doi: 10.1007/s11095-006-9075-5. Epub 2006 Aug 12. Pharm Res. 2006. PMID: 16906452 Review.

7

Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy.

Andre F, Pusztai L. Andre F, et al. Nat Clin Pract Oncol. 2006 Nov;3(11):621-32. doi: 10.1038/ncponc0636. Nat Clin Pract Oncol. 2006. PMID: 17080180 Review.

8

Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy.

Mazouni C, Hall A, Broglio K, Fritsche H, Andre F, Esteva FJ, Hortobagyi GN, Buzdar AU, Pusztai L, Cristofanilli M. Mazouni C, et al. Among authors: andre f. Cancer. 2007 Feb 1;109(3):496-501. doi: 10.1002/cncr.22418. Cancer. 2007. PMID: 17149760 Free article. Clinical Trial.

9

Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast.

Grenier J, Soria JC, Mathieu MC, Andre F, Abdelmoula S, Velasco V, Morat L, Besse B, Dunant A, Spielmann M, Delaloge S. Grenier J, et al. Among authors: andre f. Anticancer Res. 2007 Jan-Feb;27(1B):547-55. Anticancer Res. 2007. PMID: 17348440 Free article.

10

Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer.

Andre F, Hatzis C, Anderson K, Sotiriou C, Mazouni C, Mejia J, Wang B, Hortobagyi GN, Symmans WF, Pusztai L. Andre F, et al. Clin Cancer Res. 2007 Apr 1;13(7):2061-7. doi: 10.1158/1078-0432.CCR-06-2078. Clin Cancer Res. 2007. PMID: 17404087 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,141 results

Search Page

Filters